South Korea vs Malta: Treatment for hypertension, male
South Korea
67.2%
in 2019
Malta
65.1%
in 2019
South Korea rank
3rd
Malta rank
6th
Treatment for hypertension, male over time
- South Korea
- Malta
How they compare
South Korea currently reports 67.2% against 65.1% in Malta, a difference of 2.1%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Malta ahead.
South Korea ranks 3rd and Malta ranks 6th of 192 countries.
Across the 3 decades both report, South Korea averaged higher in 1 and Malta in 2.
Head to head by decade
| Decade | South Korea | Malta | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 23.7% | 36.8% | 13.1% | Malta |
| 2000s | 43.0% | 49.2% | 6.2% | Malta |
| 2010s | 61.3% | 61.3% | 0.0% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, male, South Korea or Malta?
- South Korea, at 67.2% against 65.1% in Malta as of 2019.
- What is the difference in treatment for hypertension, male between South Korea and Malta?
- 2.1%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Malta?
- 30 years are reported by both, from 1990 to 2019.
- How do South Korea and Malta rank globally for treatment for hypertension, male?
- South Korea ranks 3rd and Malta ranks 6th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.